Acridine derivatives as anti-BVDV agents

Antiviral Research

Volumn 91, Issue 2, 2011, Pages 133-141

  Tonelli, Michele ^a   Vettoretti, Gerolamo ^a   Tasso, Bruno ^a   Novelli, Federica ^a   Boido, Vito ^a   Sparatore, Fabio ^a   Busonera, Bernardetta ^b   Ouhtit, Aicha ^b   Farci, Pamela ^b   Blois, Sylvain ^b   Giliberti, Gabriele ^b   La Colla, Paolo ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

9 Aminoacridine derivatives; Anti BVDV activity; RNA and DNA viruses

Indexed keywords

2' C ETHYNYLCYTIDINE; 2' C METHYLGUANOSINE; ACICLOVIR; ACRANIL; ACRIDINE DERIVATIVE; AMINOACRIDINE; ANTIVIRUS AGENT; AZAURIDINE; M 5255; MEPACRINE; MYCOPHENOLIC ACID; NM 108; NM 176; NM 299; RIBAVIRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; DNA VIRUS; DRUG CYTOTOXICITY; DRUG SPECIFICITY; LIVESTOCK; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS;

ACRIDINES; AMINOACRIDINES; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DIARRHEA VIRUSES, BOVINE VIRAL; DIMETHYL SULFOXIDE; DNA VIRUSES; HUMANS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; RNA VIRUSES;

BOVINE VIRAL DIARRHEA VIRUS 1; DNA VIRUSES;

EID: 79958250079     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.05.005     Document Type: Article

References (45)

1. Abood, L.G., 1960. Polymethyleniminoalkylamides. Colgate-Palmolive Co. Pat. US 3185678. Chem. Abstr. 1965, 63, 4262f.
2. Baginski S.G., Pevear D.C., Seipel M., Sun S.C., Benetatos C.A., Chunduru S.K., Rice C.M., Collet M.S. Mechanism of action of a pesti virus antiviral compound. Proc. Natl. Acad. Sci. USA 2000, 97:7981-7986.
3. Boido Canu C., Boido V., Sparatore F. Preparation and antileukemic activity of quinolizidinylalkyl-derivatives of 4-aminoquinoline and 9-aminoacridine. Boll. Chim. Farm. 1989, 128:212-215.
4. Bolte J., Demuynck C., Lhomme M.F., Lhomme J., Barbet J., Roques B.P. Synthetic models related to DNA intercalating molecules: comparison between quinacrine and chloroquine in the ring-ring interaction with adenine and thymine. J. Am. Chem. Soc. 1982, 104:760-765.
5. Buckwold V.E., Beer B.E., Donis R.O. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res. 2003, 60:1-15.
6. Burckhalter J.H., Jones Eldon M., Halcomb W.F., Sweet L.A. N-Substituted 2-methoxy-6-chloro-9-aminoacridines. J. Am. Chem. Soc. 1943, 65:2012-2015.
7. Constant J.F., Carden B.M., Lhomme J. Synthetic models related to DNA intercalating molecules: preparation of 9-aminoacridines linked to the nucleotide bases adenine, guanine and thymine. J. Heterocyclic Chem. 1985, 22:1035-1040.
8. Denny W.A. Acridine derivatives as chemotherapeutic agents. Curr. Med. Chem. 2002, 9:1655-1665.
9. Finkielsztein L.M., Moltrasio G.Y., Caputto M.E., Castro E.F., Cavallaro L.V., Moglioni A.G. What is known about the antiviral agents active against bovine viral diarrhea virus (BVDV)?. Curr. Med. Chem. 2010, 17:2933-2955.
10. Gálvez-Peralta M., Hackbarth J.S., Flatten K.S., Kaufmann S.H., Hiasa H., Xing C., Ferguson D.M. On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents. Bioorg. Med. Chem. Lett. 2009, 19:4459-4462.
11. Gasparian A.V., Neznanov N., Jha S., Galkin O., Moran J.J., Gudkov A.V., Gurova K.V., Komar A.A. Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs. J. Virol. 2010, 84:9390-9397.
12. Gerchuk M.P., Arbuzova P.G., Kel'manskaya I.A. Synthesis of new chemotherapeutic pyroplasmocidic compounds. II. Synthesis of acridyl-substituted ureas. Zhurnal Obshchei Khimii 1941, 11:948-953. (Chem. Abstr. 1943, 37, 207).
13. Goodell J.R., Madhok A.A., Hiasa H., Ferguson D.M. Synthesis and evaluation of acridine- and acridone-based anti-herpes agents with topoisomerase activity. Bioorg. Med. Chem. 2006, 14:5467-5480.
14. Glaz E.T., Szolgay E., Stöger I., Talas M. Antiviral activity and induction of interferon-like substance by quinacrine and acranil. Antimicrob. Agents Chemother. 1973, 3:537-541.
15. Glaz E.T., Talas M. Comparison of the activity of small molecular interferon inducers: tilorone and acridine drugs. Arch. Virol. 1975, 48:375-384.
16. Goodman L.S., Gilman A. The pharmacological basis of therapeutics 1965, Macmillan, New York, pp. 1072-1090. third ed.
17. Greenhalgh N., Hull R., Hurst E.V. The antiviral activity of acridines in eastern equine encephalomyelitis, rift valley fever and psittacosis in mice, and lymphogranuloma venereum in chick-embryos. Brit. J. Pharmacol. 1956, 11:220-224.
18. Guendel I., Carpio L., Easley R., Van Duyne R., Coley W., Agbottah E., Dowd C., Kashanchi F., Kehn-Hall K. 9-Aminoacridine inhibition of HIV-1 Tat dependent transcription. Virol. J. 2009, 6:114-127.
19. Guo C., Gasparian A.V., Zhuang Z., Bosykh D.A., Komar A.A., Gudkov A.V., Gurova K.V. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kB and p53 pathways. Small molecules targeting AKT/mTOR, PI3K, NF-kB and p53pathways. Oncogene 2009, 28:1151-1161.
20. Gurova K. New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents. Fut. Oncol. 2009, 5:1685-1704.
21. Houe H. Economic impact of BVDV infection in dairies. Biologicals 2003, 31:137-143.
22. Hurst E.W., Melvin P., Peters J.M. The prevention of encephalitis due to the viruses of eastern equine encephalomyelitis and louping-ill: experiments with trypan red, mepacrine, and many other substances. Brit. J. Pharmacol. 1952, 7:455-472.
23. Hurst E., Melvin P., Peters J.M. The action of mepacrine and trypan red in a number of virus diseases. Brit. J. Pharmacol. 1952, 7:473-481.
24. Jamison J.M., Krabill K., Allen K.A., Stuart S.H., Tsai C.-C. RNA-intercalating agent interactions: in vitro antiviral activity studies. Antiviral Chem. Chemother. 1990, 1:333-347.
25. Jung K.-J., Dasgupta A., Huang K., Jeong S.-J., Pise-Masison C., Gurova K., Brady J.N. Small-molecule inhibitor which reactivates p53 in human T-cell leukemia virus type 1-transformed cells. J. Virol. 2008, 82:8537-8547.
26. King R.W., Scarnati H.T., Priestley E.S., De Lucca I., Bansal A., Williams J.K. Selection of a thiazole urea-resistant variant of bovine viral diarrhea virus that maps to the RNA-dependent RNA polymerase. Antiviral Chem. Chemother. 2002, 13:315-323.
27. Korth C., May B.C.H., Cohen F.E., Prusiner S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. PNAS 2001, 98:9836-9841.
28. Magidson O.Yu., Grigorovskii A.M. Acridine compounds and their antimalarial action. I. Chem. Ber. 1936, 69:396-412.
29. Magidson O.Yu., Grigorovskii A.M., Gal'perin E.P. Acridine derivatives as a source of medicinal products. IV. The effect of the changes of the substituents in the positions 2 and 6 and of the amino groups in the side chain on the antimalarial activity. Zhurnal Obshchei Khimii 1938, 8:56-65. (Chem. Abstr. 1938, 32: 38835).
30. Manfroni G., Paeshuyse J., Massari S., Zanoli S., Gatto B., Maga G., Tabarrini O., Cecchetti V., Fravolini A., Neyts J. Inhibition of subgenomic hepatitis C virus RNA replication by acridone derivatives: identification of an NS3 helicase inhibitor. J. Med. Chem. 2009, 52:3354-3365.
31. Neznanov N., Gorbachev A.V., Neznanova L., Komarov A.P., Gurova K.V., Gasparian A.V., Banerjee A.K., Almasan A., Fairchild R.L., Gudkov A.V. Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications. Cell Cycle 2009, 8:3960-3970.
32. Okamoto M., Sakai M., Goto Y., Salim M.T., Baba C., Goto K., Watashi K., Shimotohno K., Baba M. Anti-bovine viral diarrhoea virus and hepatitis C virus activity of the cyclooxygenase inhibitor SC-560. Antivir. Chem. Chemother. 2009, 20:47-54.
33. Paeshuyse J., Leyssen P., Mabery E., Boddeker N., Vrancken R., Froeyen M., Ansari I.H., Dutartre H., Rozenski J., Gil L.H.V.G., Letellier C., Lanford R., Canard B., Koenen F., Kerkhofs P., Donis R.O., Herdewijn P., Watson J., De Clercq E., Puerstinger G., Neyts J. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J. Virol. 2006, 80:149-160.
34. Patterson, L.H., Pors, K., Teesdale-Spittle, P.H., 2005. A preparation of anthraquinone derivatives, useful as antitumor agents. Pat. WO 2005061453 A1.
35. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. A rapid and automated tetrazodium-based colorimetric assay for the detection of anti-HIV compound. J. Virol. Methods 1988, 20:309-321.
36. Sasvari Z., Bach S., Blondel M., Nagy P.D. Inhibition of RNA recruitment and replication of an RNA virus by acridine derivatives with known anti-prion activities. PLoS One 2009, 4:e7376. 10.1371/journal.pone.0007376.
37. Sebestik J., Hlavacek J., Stibor I. A role of the 9-aminoacridines and their conjugates in a life science. Curr. Protein Pept. Sci. 2007, 8:471-483.
38. Seio K., Sasaki T., Yanagida K., Baba M., Sekine M. Synthesis of benzodithiol-2-yl-substituted nucleoside derivatives as lead compounds having anti-bovine viral diarrhea virus activity. J. Med. Chem. 2004, 47:5265-5275.
39. Sun J.-H., Lemm J.A., O'Boyle D.R., Racela J., Colonno R., Gao M. Specific inhibition of bovine viral diarrhea virus replicase. J. Virol. 2003, 77:6753-6760.
40. Tabarrini O., Manfroni G., Fravolini A., Cecchetti V., Sabatini S., De Clercq E., Rozenski J., Canard B., Dutartre H., Paeshuyse J., Neyts J. Synthesis and anti-BVDV activity of acridones as new potential antiviral agents. J. Med. Chem. 2006, 49:2621-2627.
41. Tonelli M., Boido V., Canu C., Sparatore A., Sparatore F., Paneni M.S., Fermeglia M., Pricl S., La Colla P., Casula L., Ibba C., Collu D., Loddo R. Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines. Bioorg. Med. Chem. 2008, 16:8447-8465.
42. Tonelli M., Vazzana I., Tasso B., Boido V., Sparatore F., Fermeglia M., Paneni M.S., Posocco P., Pricl S., La Colla P., Ibba C., Secci B., Collu G., Loddo R. Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives. Bioorg. Med. Chem. 2009, 17:4425-4440.
43. Tonelli M., Simone M., Tasso B., Novelli F., Boido V., Sparatore F., Paglietta G., Pricl S., Giliberti G., Blois S., Ibba C., Sanna G., Loddo R., La Colla P. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-Phenylbenzimidazole derivatives. Bioorg. Med. Chem. 2010, 18:2937-2953.
44. Villa V., Tonelli M., Thellung S., Corsaro A., Tasso B., Novelli F., Canu C., Pino A., Chiovitti K., Paludi D., Russo C., Sparatore A., Aceto A., Boido V., Sparatore F., Florio T. Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity. Neurotox. Res. 2010, 10.1007/s12640-010-9189-8.
45. Wainwright M. Acridine - a neglected antibacterial chromophore. J. Antimicrob. Chemother. 2001, 47:1-13.